Supernus Pharmaceuticals
SUPN
#4182
Rank
S$3.39 B
Marketcap
S$59.20
Share price
1.29%
Change (1 day)
19.56%
Change (1 year)

Supernus Pharmaceuticals (SUPN) - Total assets

Total assets on the balance sheet as of September 2025 : S$1.83 Billion

According to Supernus Pharmaceuticals 's latest financial reports the company's total assets are S$1.83 Billion. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

Supernus Pharmaceuticals - Total assets on balance sheet (from 2009 to 2025)

Total assets by year

Year Total assets Change
2024-12-31S$1.85 B10.2%
2023-12-31S$1.68 B-26.07%
2022-12-31S$2.28 B-0.05%
2021-12-31S$2.28 B14.76%
2020-12-31S$1.98 B27.21%
2019-12-31S$1.56 B17.1%
2018-12-31S$1.33 B135.3%
2017-12-31S$0.56 B26.71%
2016-12-31S$0.44 B67.92%
2015-12-31S$0.26 B47.63%
2014-12-31S$0.18 B28.52%
2013-12-31S$0.14 B22.35%
2012-12-31S$0.11 B65.18%
2011-12-31S$69.58 M14.91%
2010-12-31S$60.55 M-46.02%
2009-12-31S$0.11 B1.69%
2008-12-31S$0.11 B

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
Zogenix
ZGNX
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA
United Therapeutics
UTHR
S$9.52 B 417.77%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
S$148.94 B 7,995.44%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
S$125.55 B 6,724.37%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
S$109.09 B 5,829.28%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
S$249.87 B 13,480.98%๐Ÿ‡บ๐Ÿ‡ธ USA